Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 07 Jan 2025

Analysis of drug pricing drivers under South Korea’s pharmaco-economic evaluation exemption policy (2015–2022)

in Drugs Outcomes Research and Policies

Seung Rae Yu
Jong Hyuk Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1519491

903 views

Original Research

Published on 07 Jan 2025

Cost-effectiveness of tyrosine kinase inhibitor treatment strategies for chronic myeloid leukemia in South Africa

in Drugs Outcomes Research and Policies

Rochelle Woudberg
Edina Sinanovic

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1511603

1,012 views

Original Research

Published on 07 Jan 2025

Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in the Chinese healthcare system

in Drugs Outcomes Research and Policies

Wenwang Lang
Yulong He
Changchun Hou
Hua Li
Qinling Jiang
Liuyong Mei

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1402423

844 views

Original Research

Published on 07 Jan 2025

Pharmacists’ perceptions of the new pharmaceutical vaccination service in Romania: a comprehensive first two-years evaluation

in Drugs Outcomes Research and Policies

Corneliu-Florin Buicu
Mihaela-Simona Naidin
Marius Calin Chereches
Marina-Daniela Dimulescu
Adina Turcu-Stiolica

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1476504

1,352 views

Original Research

Published on 07 Jan 2025

Correlation between the white blood cell/platelet ratio and 28-day all-cause mortality in cardiac arrest patients: a retrospective cohort study based on machine learning

in Drugs Outcomes Research and Policies

Huai Huang
Guangqin Ren
Shanghui Sun
Zhi Li
Yongtian Zheng
Lijuan Dong
Shaoliang Zhu
Xiaosheng Zhu
Wenyu Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1527664

1,342 views

Original Research

Published on 06 Jan 2025

A network comparison on efficacy and safety profiling of PD-1/PD-L1 inhibitors in first-line treatment of advanced non-small cell lung cancer

in Drugs Outcomes Research and Policies

Jie Fu
Yi-Dan Yan
Xu Wan
Xiao-Fan Sun
Xiu-Mei Ma
Ying-Jie Su

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1516735

1,328 views

Systematic Review

Published on 06 Jan 2025

Association between penicillin allergy labels and serious adverse events in hospitalized patients: a systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Shipeng Zhang
Tianyi Dong
Jiawen Xian
Xinyue Xiao
Jiaqing Yuan
Tong Zeng
Kuan Deng
Rui Fu
Hanyu Wang
Yanjie Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1519522

960 views

Review

Published on 06 Jan 2025

Comparing efficacy and safety of low-dose versus standard-dose antiplatelet therapy in stroke patients: a meta-analysis

in Drugs Outcomes Research and Policies

Zhao Ren
Chunxing Li
Xin Zhang
Lichaoyue Sun
Hui Zhu
Dongxiao Wang
Yumin Wang
Shuo Liang
Guanchun Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1484130

878 views

Review

Published on 03 Jan 2025

Efficacy, safety and cost-effectiveness of obinutuzumab in patients with follicular lymphoma: a rapid review

in Drugs Outcomes Research and Policies

Chao Wang
Yunzhuo Dong
Peng Men
Ruixia Zhang
Ying Xiao
Yishan Bu
Yinpeng Qin
Xinran Zhang
Qianqian Dou
Yiheng Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1426772

1,389 views

Review

Published on 24 Dec 2024

Cutaneous adverse events associated with BRAF and MEK inhibitors: a systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Junhui Qian
Jinlong Wan
Qin Yao
Yin Chen
Tao Ling
Yuejuan Zhang
Zhihua Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1457226

1,088 views

Original Research

Published on 23 Dec 2024

Medication non-adherence: reflecting on two decades since WHO adherence report and setting goals for the next twenty years

in Drugs Outcomes Research and Policies

Przemyslaw Kardas
Bryan Bennett
Bijan Borah
Michel Burnier
Christopher Daly
Mickael Hiligsmann
Enrica Menditto
Andrew M. Peterson
Julia F. Slejko
Krisztina Tóth

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1444012

4,958 views

Original Research

Published on 20 Dec 2024

Cost-effectiveness analysis of first-line combination chemotherapy regimens for metastatic pancreatic cancer and evidence-based pricing strategy of liposomal irinotecan in China

in Drugs Outcomes Research and Policies

Zuojuan Xiang
Ling Ma
Zhengxiong Li
Yingzhou Fu
Yong Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488645

1,271 views

Systematic Review

Published on 19 Dec 2024

Factors affecting posaconazole plasma concentrations: a meta-analysis and systematic review

in Drugs Outcomes Research and Policies

Ruochen Qu
Yan Liu
Yan Zhao
Ziyi Wang
Shizhao Yuan
Shuai Liu
Jing Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1450120

886 views

Systematic Review

Published on 18 Dec 2024

Literature review analysis of aortitis induced by granulocyte-colony stimulating factor

in Drugs Outcomes Research and Policies

Ting Zhao
Huanhuan Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1487501

878 views

Original Research

Published on 18 Dec 2024

Non-persistence with multiple secondary prevention medications for peripheral arterial disease among older hypertensive patients

in Drugs Outcomes Research and Policies

Martin Wawruch
Miriam Petrova
Denisa Celovska
Sofa D. Alfian
Tomas Tesar
Jan Murin
Michal Trnka
Tomas Paduch
Emma Aarnio

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1464689

748 views

Perspective

Published on 17 Dec 2024

Sustainable integration of artificial intelligence and machine learning approaches within the African infectious disease vaccine research and development ecosystem

in Drugs Outcomes Research and Policies

Jonathan Hare
Morten Nielsen
Agnes Kiragga
Daniel Ochiel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1499079

1,248 views
1 citation